Susquehanna International Group
AMED

Susquehanna International Group’s Amedisys AMED Stock Holding History

Susquehanna International Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,200
Closed -$1.3M – 12284
2025
Q2 		$1.3M Buy
13,200
+2,800
+27% +$265K ﹤0.01% 6775
2025
Q1 		$963K Sell
10,400
-90,300
-90% -$8.33M ﹤0.01% 7352
2024
Q4 		$9.14M Buy
100,700
+46,500
+86% +$4.27M ﹤0.01% 2765
2024
Q3 		$5.23M Buy
54,200
+10,800
+25% +$1.05M ﹤0.01% 3524
2024
Q2 		$3.98M Buy
43,400
+8,700
+25% +$807K ﹤0.01% 3817
2024
Q1 		$3.2M Sell
34,700
-64,000
-65% -$6M ﹤0.01% 4399
2023
Q4 		$9.38M Buy
98,700
+41,400
+72% +$3.87M ﹤0.01% 2718
2023
Q3 		$5.35M Buy
57,300
+100
+0.2% +$9.24K ﹤0.01% 3403
2023
Q2 		$5.23M Buy
+57,200
New +$4.69M ﹤0.01% 3456
2023
Q1 		– Sell
-11,600
Closed -$969K – 12491
2022
Q4 		$969K Sell
11,600
-8,900
-43% -$802K ﹤0.01% 6269
2022
Q3 		$1.98M Sell
20,500
-49,400
-71% -$5.89M ﹤0.01% 4942
2022
Q2 		$7.35M Buy
69,900
+33,000
+89% +$4.22M ﹤0.01% 2625
2022
Q1 		$6.36M Buy
36,900
+18,700
+103% +$2.79M ﹤0.01% 3248
2021
Q4 		$2.95M Sell
18,200
-83,500
-82% -$13.4M ﹤0.01% 4677
2021
Q3 		$15.2M Buy
101,700
+32,100
+46% +$6.67M ﹤0.01% 2300
2021
Q2 		$17M Buy
69,600
+56,400
+427% +$14.8M ﹤0.01% 2240
2021
Q1 		$3.5M Sell
13,200
-1,900
-13% -$536K ﹤0.01% 4639
2020
Q4 		$4.43M Sell
15,100
-43,100
-74% -$11.1M ﹤0.01% 3612
2020
Q3 		$13.8M Buy
58,200
+32,000
+122% +$7.28M ﹤0.01% 1848
2020
Q2 		$5.2M Sell
26,200
-300
-1% -$56K ﹤0.01% 2954
2020
Q1 		$4.86M Sell
26,500
-17,200
-39% -$3.06M ﹤0.01% 2608
2019
Q4 		$7.29M Buy
43,700
+11,300
+35% +$1.68M ﹤0.01% 2467
2019
Q3 		$4.25M Sell
32,400
-16,300
-33% -$2.12M ﹤0.01% 2945
2019
Q2 		$5.91M Sell
48,700
-64,300
-57% -$7.63M ﹤0.01% 2491
2019
Q1 		$13.9M Buy
113,000
+92,500
+451% +$11.6M 0.01% 1469
2018
Q4 		$2.4M Sell
20,500
-3,100
-13% -$365K ﹤0.01% 3253
2018
Q3 		$2.95M Buy
23,600
+4,100
+21% +$453K ﹤0.01% 3387
2018
Q2 		$1.67M Buy
19,500
+4,000
+26% +$294K ﹤0.01% 4336
2018
Q1 		$935K Sell
15,500
-2,200
-12% -$125K ﹤0.01% 5380
2017
Q4 		$933K Sell
17,700
-9,300
-34% -$490K ﹤0.01% 5381
2017
Q3 		$1.51M Sell
27,000
-37,400
-58% -$1.98M ﹤0.01% 4447
2017
Q2 		$4.04M Buy
64,400
+8,100
+14% +$472K ﹤0.01% 2685
2017
Q1 		$2.88M Buy
56,300
+49,700
+753% +$2.37M ﹤0.01% 3096
2016
Q4 		$281K Buy
6,600
+2,000
+43% +$85K ﹤0.01% 8092
2016
Q3 		$218K Sell
4,600
-1,200
-21% -$59.9K ﹤0.01% 7445
2016
Q2 		$293K Sell
5,800
-79,000
-93% -$3.99M ﹤0.01% 6995
2016
Q1 		$4.1M Buy
84,800
+69,900
+469% +$2.7M ﹤0.01% 2579
2015
Q4 		$586K Sell
14,900
-10,500
-41% -$420K ﹤0.01% 6457
2015
Q3 		$964K Sell
25,400
-35,800
-58% -$1.51M ﹤0.01% 5829
2015
Q2 		$2.43M Buy
61,200
+17,700
+41% +$552K ﹤0.01% 4289
2015
Q1 		$1.17M Buy
43,500
+14,000
+47% +$395K ﹤0.01% 5434
2014
Q4 		$866K Sell
29,500
-1,600
-5% -$39.5K ﹤0.01% 6141
2014
Q3 		$627K Sell
31,100
-39,700
-56% -$766K ﹤0.01% 6803
2014
Q2 		$1.19M Sell
70,800
-14,400
-17% -$204K ﹤0.01% 5687
2014
Q1 		$1.27M Buy
85,200
+36,400
+75% +$560K ﹤0.01% 5100
2013
Q4 		$714K Sell
48,800
-29,400
-38% -$473K ﹤0.01% 6101
2013
Q3 		$1.35M Sell
78,200
-7,700
-9% -$114K ﹤0.01% 4793
2013
Q2 		$998K Buy
+85,900
New +$984K ﹤0.01% 5000

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's AMED Position: Q2 2025 in Review

Susquehanna International Group sold out of Amedisys (AMED) in Q2 2025, closing a stake of 6,440 shares — an estimated $609K sold.

Susquehanna International Group first reported a position in AMED in Q4 2013 and held it in 33 quarters. The position peaked at $13.6M in Q2 2023. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Susquehanna International Group reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 6,440 Amedisys shares in Q2 2025, an estimated $609K.
  • Susquehanna International Group first reported a position in Amedisys in Q4 2013 and held it in 33 quarters.
  • Susquehanna International Group's Amedisys position peaked at $13.6M in Q2 2023.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.